Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Hemostasis Tests Market Report Overview

The hemostasis tests market size was valued at $594.3 million in 2023. The hemostasis tests market will grow at a CAGR of more than 1% from 2023 to 2033. The increasing prevalence of surgical cases, rise in VTE incidence, and demand for point of care (POC) coagulation testing are driving factors for the growth of the hemostasis testing market. There is demand for POC tests for hemostasis tests due to the time-consuming process of laboratory-based tests that can lead to treatment delays. These diagnostic tests provide rapid results, reduce hospital stays and lead to immediate treatment decisions.

Hemostasis Tests Market Outlook 2023-2033 ($ Billion)

Hemostasis Tests Market Outlook 2023-2033 ($ Billion)

Buy the Full Report for More Insights on the Hemostasis Tests Market Forecast, Download a Free Sample Report

The hemostasis tests market research report explains the market behavior, which will help identify quantitative market trends within in vitro diagnostics therapeutic areas. The report has extensively covered regional-wise quantitative data, highlighting the number of hemostasis tests across labs, which will help in identifying untapped market opportunities. The hemostasis tests market model also discusses the detailed impact of COVID-19 on the hemostasis tests market for 2020 and beyond.

Market Size (2023) $594.3 million
CAGR (2023-2033) >1%
Historic Period 2015-2023
Forecast Period 2023-2033
Key Segments
  • Activated Partial Thromboplastin Time Laboratory Tests
  • Activated Partial Thromboplastin Time Point of Care (POC) Tests
  • D-Dimer Laboratory Tests
  • D-Dimer Point of Care (POC) Tests
  • Prothrombin Time Laboratory Tests
  • Prothrombin Time Point of Care (POC) Tests
Key Regions
  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South and Central America
Key Companies
  • Abbott Laboratories
  • Roche Diagnostics International Ltd
  • Siemens Healthineers AG
  • Diagnostica Stago SAS
  • Instrumentation Laboratory Co
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Hemostasis Tests Market Dynamics

The prevalence of surgical cases is increasing in many countries and geographical regions. This is expected to lead to higher numbers of prothrombin (PT) tests and activated partial thromboplastin Time (aPTT) tests being used. The incidence of Venous Thromboembolism (VTE) is also increasing worldwide, which is expected to drive sales of D-Dimer tests during the forecast period.

Sales of these devices are also impacted by fluctuations in the number of cases prescribed Vitamin-K antagonists such as warfarin sodium and the average number of annual “Hemostasis tests” performed per case. Usage of warfarin sodium is decreasing in many countries, due to the growing popularity of direct oral anticoagulants such as apixaban, rivaroxaban, edoxaban. This is expected to cause a decline in some North American, European, APAC, and the Middle East, and African markets, primarily for PT tests. Finally, gains in the D-Dimer tests market are expected to bolster the growth of the “Hemostasis Tests” market overall, as D-Dimer tests tend to be more expensive than PT or aPTT tests. With the expanding role of DOACs, clinicians are faced with increasingly complex decisions relating to the appropriate agent, duration of treatment, and use in special populations.

Buy the Full Report for Additional Hemostasis Tests Market Dynamics, Download a Free Sample Report

Hemostasis Tests Market Segments

The key segments in the hemostasis tests market are Activated Partial Thromboplastin Time Laboratory Tests, Activated Partial Thromboplastin Time Point of Care (POC) Tests, D-Dimer Laboratory Tests, D-Dimer Point of Care (POC) Tests, Prothrombin Time Laboratory Tests, and Prothrombin Time Point of Care (POC) Tests. In 2023, the Prothrombin Time Point of Care (POC) Tests segment dominated the market share. The segment is likely to dominate the market during the projected period.

Hemostasis Tests Market Analysis by Segments, 2023 (%)

Hemostasis Tests Market Analysis by Segments, 2023 (%)

Buy the Full Report for More Segment-Wise Insights about the Hemostasis Tests Market Segments, Download a Free Sample Report

Hemostasis Tests Market Segmentation by Regions

The key regions in the hemostasis tests market are Asia-Pacific, Europe, the Middle East and Africa, North America, and South and Central America. In 2023, North America was the leading regional segment in the hemostasis tests market.

In the US, Canada, and Mexico prothrombin (PT) tests are preferred hemostasis tests to monitor oral anticoagulants (Vitamin-K antagonists) such as warfarin, phenprocoumon, and acenocumarol. These tests also help to identify coagulation abnormalities in the perioperative period.

Hemostasis Tests Market Analysis by Regions, 2023 (%)

Hemostasis Tests Market Analysis by Regions, 2023 (%)

Buy the Full Report for More Regional Insights in the Hemostasis Tests Market, Download A Free Sample Report

Hemostasis tests Market – Competitive Landscape

The key companies in the hemostasis tests market are Abbott Laboratories, Roche Diagnostics International Ltd, Siemens Healthineers AG, Diagnostica Stago SAS, Instrumentation Laboratory Co, and Quidel Corp among others. In 2023, Abbott Laboratories accounted for the highest hemostasis tests market share and value.

Hemostasis Tests Market Analysis by Companies, 2023 (%)

Hemostasis Tests Market Analysis by Companies, 2023 (%)

Buy the Full Report for More Company-Wise Insights into the Hemostasis Tests Market, Download a Free Sample Report

Segments Covered in this Report.

Hemostasis Tests Segment Outlook ($ Million, 2015-2033)

  • Activated Partial Thromboplastin Time Laboratory Tests
  • Activated Partial Thromboplastin Time Point of Care (POC) Tests
  • D-Dimer Laboratory Tests
  • D-Dimer Point of Care (POC) Tests
  • Prothrombin Time Laboratory Tests
  • Prothrombin Time Point of Care (POC) Tests

Hemostasis Tests Regional Outlook ($ Million, 2015-2033)

  • Asia-Pacific
  • Europe
  • Middle East and Africa
  • North America
  • South and Central America

Key Inclusions of the market model are –

Currently marketed hemostasis tests market and evolving competitive landscape:

  • Insightful review of the key industry trends.
  • Annualized total hemostasis tests market revenue by segment and market outlooks from 2015-2033.
  • Market-level data on units, average selling prices, and market values.

Global, Regional and Country level market specific insights:

  • Qualitative market-specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country-specific insights on the market.
  • SWOT analysis for the Hemostasis tests market.
  • Competitive dynamics insights and trends provided for the hemostasis tests market.

Get an in-depth understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country-specific overview of the healthcare system.
  • Country-specific reimbursement policies.
  • Country-specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide an extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real-world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories, F. Hoffmann-La Roche Ltd, Siemens AG, Diagnostica Stago SAS, Werfen Life Group SAU, Bio-Rad Laboratories Inc, bioMerieux SA, Quidelortho Corp, Danaher Corp, Revvity Inc, and others.

Countries covered – United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won’t find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is essential for the following stakeholders:

  • CMO executives who must have a deep understanding of the hemostasis tests marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

  • Understand the impact of COVID-19 on hemostasis tests.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving hemostasis tests.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the hemostasis tests market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company’s share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific hemostasis tests market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.

Abbott Laboratories
F. Hoffmann-La Roche Ltd
Siemens AG
Diagnostica Stago SAS
Werfen Life Group SAU
Bio-Rad Laboratories Inc
bioMerieux SA
Quidelortho Corp
Danaher Corp
Revvity Inc

Frequently asked questions

Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 thematic reports
Currency USD
$7,500

Can be used by individual purchaser only

$22,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 in real time.

  • Access a live Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.